Nicotinamide improves insulin secretion and metabolic control in lean type 2 diabetic patients with secondary failure to sulphonylureas

Acta Diabetologica

Volumn 35, Issue 1, 1998, Pages 61-64

  Polo, V ^a   Saibene, A ^b   Pontiroli, A E ^c  

^a RHO HOSPITAL   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

C peptide release; Nicotinamide; Secondary failure; Sulphonylurea

Indexed keywords

C PEPTIDE; GLUCAGON; GLUCOSE; HEMOGLOBIN A1C; INSULIN; NICOTINAMIDE; SULFONYLUREA;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RELEASE; MALE; METABOLIC REGULATION; MULTIPLE REGRESSION; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT FAILURE;

ADULT; C-PEPTIDE; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; NIACINAMIDE; RETREATMENT; SINGLE-BLIND METHOD; SULFONYLUREA COMPOUNDS; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0031801313     PISSN: 09405429     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005920050103     Document Type: Article

References (18)

1. Pontiroli AE, Calderara A, Pozza G (1994) Secondary failure of oral hypoglycemic agents: frequency, possible causes, and management. Diabetes/Metab Rev 10: 31-43
2. Pontiroli AE, Calderara A, Capra F, Fattor B, Illeni MT, Pozza G (1987) HLA phenotype and secondary failure to oral hypoglycaemic agents. Diabetologia 30: 824-825
3. Gale EAM (1996) Molecular mechanisms of beta cell destruction in IDDM. The role of nicotinamide. Hormone Res 45 [Suppl 1]: 40-43
4. Pozzilli P, Browne PD, Kolb H, The Nicotinamide Trialists (1996) Meta-analysis of nicotinamide treatment in patients with recent-onset IDDM. Diabetes Care 19: 1357-1363
5. Elliot RB, Chase HP (1991) Prevention or delay of type I (insulin-dependent) diabetes mellitus using nicotinamide Diabetologia 34: 362-365
6. Herskowitz RD, Jackson RA, Soeldner JS, Eisenbarth GS (1989) Pilot trial to prevent type I diabetes: progression to overt IDDM despite oral nicotinamide. J Autoimmun 2: 733-737
7. Davalli AM, Ricordi C, Socci C, Braghi S, Bertuzzi F, Fattor B, Di Carlo V, Pontiroli AE, Pozza G (1991) Abnormal sensitivity to glucose of human islets cultured in a high glucose medium: partial reversibility after an additional culture in a normal glucose medium. J Clin Endocrinol Metab 72: 202-208
8. Kosaka K, Kuzuya T, Akanuma Y, Hagura R (1980) Increase in insulin response after treatment of overt maturity-onset diabetes is independent of the mode of treatment. Diabetologia 18: 23-28
9. Giugliano D, Ceriello A, Paolisso G (1996) Oxidative stress and diabetic vascular complications. Diabetes Care 10: 257-267
10. Eizirik DL, Kisby GE (1995) Cycad toxin-induced damage of rodent and human pancreatic β-cells. Biochem Pharmacol 50: 355-365
11. Kaneto H, Fujii J, Myint T, Miyazawa N, Islam KN, Kawasaki Y, Suzuki K, Nakamura M, Tatsumi H, Yamasaki Y, Taniguchi N (1996) Reducing sugars trigger oxidative modification and apoptosis in pancreatic β-cells by provoking oxidative stress through the glycation reaction. Biochem J 320: 855-863
12. Fukuda M, Ikegami H, Kawaguchi Y, Sano T, Ogihara T (1995) Antioxidant, probucol, can inhibit the generation of hydrogen peroxide in islet cells induced by macrophages and prevent islet cell destruction in NOD mice. Biochem Biophys Res Commun 209: 953-958
13. Bouix G, Reynier M, Guintrand-Hugret R, Orsetti A (1995) Protective effect of gamma-hydroxybutyrate and nicotinamide on low-dose streptozotocin-induced diabetes in mice. Horm Metab Res 27: 216-220
14. Zhu M, Noma Y, Mizuno A, Sano T, Shima K (1996) Poor capacity for proliferation of pancreatic B-cells in Otsuka-Long-Evans-Tokushima fatty rats: a model of spontaneous NIDDM. Diabetes 45: 941-946
15. Korsgren O, Andersson A, Sandler S (1993) Pretreatment of fetal porcine pancreas in culture with nicotinamide accelerates reversal of diabetes after transplantation to nude mice. Surgery 113: 205-214
16. Sandler S, Hellerstrom C, Eizirk DL (1993) Effects of nicotinamide supplementation on human pancreatic islet function in tissue culture. J Clin Endocrinol Metab 77: 1574-1576
17. Bingley PJ, Caldas G, Bonfanti R, Gale EAM (1993) Nicotinamide and insulin secretion in normal subjects. Diabetologia 36: 675-677
18. Andersen HU, Jorgensen KH, Egeberg J, Mandrup-Poulsen T, Nerup J (1994) Nicotinamide prevents interleukin-1 effects on accumulated insulin release and nitric oxide production in rat islets of Langerhans. Diabetes 43: 770-777